Nuix Lifts ACV 13% and EBITDA 60.4% as Shares Fall 24.66%
Nuix reported record FY 2026 results, with annualised contract value up 13% and EBITDA growth of 60.4%, yet its NXLLF line last closed down 24.66% at 0.61.

Nuix Ltd said its FY 2026 results were a record, with annualised contract value up 13% and EBITDA growth of 60.4%, while its NXLLF shares closed at 0.61 on 21 August 2026, down 24.66% on the day.
Nuix Ltd (NXLLF) told investors its FY 2026 was a record year, pairing a 13% rise in annualised contract value with EBITDA growth of 60.4% and continued spending on artificial intelligence and research and development. The market’s reaction to the software group’s numbers has been anything but celebratory: the NXLLF line last changed hands at 0.61, down 24.66% from a previous close of 0.81, and traded in a flat band of 0.61 to 0.61 through the session ended 21 August 2026.
That gap between the reported figures and the share price is the story worth unpacking. Two headline numbers moving at very different speeds — a low-teens revenue-quality metric and an earnings metric growing more than four times as fast — usually says something about where the growth is coming from.
What ACV up 13% actually measures
Annualised contract value, or ACV, is the run-rate value of a software company’s contracted subscriptions expressed on a twelve-month basis. It is the metric investors in enterprise software watch most closely because it strips out the timing noise of multi-year deals and licence recognition, and it is a forward-looking proxy: today’s ACV is roughly the revenue base you start next year with.
A 13% increase, on Nuix’s own account, is real underlying commercial progress. Software of this kind — investigative and data-analytics tooling used by law enforcement, regulators, corporate legal teams and financial-crime units — is sticky once embedded in a workflow. Growth in ACV therefore tends to reflect a mix of new logos, seat expansion inside existing customers, and price. Nuix did not break those components out in the material available, and the distinction matters: expansion inside a fixed customer base is cheaper to win but eventually caps out, while new-customer growth costs more up front and lasts longer.
Why EBITDA grew 60.4% and revenue quality did not
EBITDA — earnings before interest, tax, depreciation and amortisation, a rough proxy for operating cash generation — grew 60.4%. When an earnings line grows at roughly five times the pace of the contract base beneath it, the arithmetic is almost always operating leverage: revenue rising against a cost base that is flat or falling, rather than a sudden change in the demand picture.
Operating leverage is genuinely valuable in subscription software. Once the platform is built, incremental contract value carries very high gross margin, and a company that has finished a heavy investment cycle can convert modest top-line growth into outsized profit growth for several years. That is the bull case, and it is a legitimate one.
The bear case is that leverage of this magnitude is not repeatable. A 60.4% EBITDA increase off a low base is a different animal from a 60.4% increase off a mature one, and it can be flattered by cost actions taken in the prior year, by capitalised development spending that lands below the EBITDA line, or by non-recurring items. Nuix’s simultaneous emphasis on “strategic investments in AI and R&D” cuts both ways: it signals management is funding the next product cycle, but investment spending is precisely what compresses margins in the years it is being made. You cannot hold both the record-margin story and the heavy-investment story constant indefinitely.
The Neo platform question
Nuix’s disclosure of a sharply higher contribution from its Neo platform is the single most important detail for anyone trying to judge durability. Platform migrations in enterprise software follow a familiar arc: legacy licence revenue erodes while the new platform compounds off a small base, and reported growth rates look spectacular until the two lines cross. What investors need from here is the absolute size of the Neo book, not its growth rate — the percentage tells you the base was small, not that the destination is large.
Nuix’s disclosure of a sharply higher contribution from its Neo platform is the single most important detail for anyone trying to judge durability.
The wider trend is in Nuix’s favour. Regulatory investigation, e-discovery and financial-crime workloads are expanding as data volumes grow, and generative AI has made unstructured-data processing a board-level budget line rather than a legal-department one. Whether Nuix captures that budget or merely competes for it against far larger platform vendors is the strategic question the FY 2026 numbers do not answer. Details of the earnings call were reported by GuruFocus.
A 24.66% drop against a market that closed higher
The share reaction is stark in context. On the same session, the S&P 500 tracker (SPY) closed at $765.72, up 0.41%; the Nasdaq 100 proxy (QQQ) finished at $713.44, up 0.35%; and the Dow tracker (DIA) closed at $532.22, up 0.89%. Broad U.S. equities went up. NXLLF went down almost a quarter.
Two cautions on reading too much into that. First, NXLLF is an over-the-counter line for a foreign-listed issuer, and such lines are typically thin. The day’s range — 0.61 at the low, 0.61 at the high, on a previous close of 0.81 — is the signature of a stock that traded once or barely at all, not of a full session of two-way price discovery. A single print can produce a headline percentage move that a liquid primary listing would never show. Second, the primary market’s verdict, not the OTC print, is what sets the real valuation.
Even allowing for that, a move of this size after a self-described record year points to something in the detail that disappointed: guidance, cash conversion, the composition of the ACV growth, or the size of the AI and R&D commitment ahead.
What to check next
- The split of ACV growth between new customers and expansion inside existing accounts. Expansion-led growth is cheaper but has a ceiling.
- Absolute Neo revenue alongside the growth rate, plus the rate of legacy decline. The crossover point is the number that matters.
- Cash conversion — how much of the 60.4% EBITDA gain reaches free cash flow after capitalised development spending.
- The size and duration of the AI and R&D programme, since it determines whether FY 2026’s margin is a floor or a peak.
- Liquidity in the NXLLF line before treating any single OTC print as a valuation signal; the primary listing is the reference price.
The verdict on Nuix’s year rests on which of the two headline numbers proves more durable. A 13% ACV increase is a demand signal that can be repeated. A 60.4% EBITDA increase, absent a step-change in the revenue base, generally cannot be — and the more a company spends on AI and R&D, the less likely it is to try.
Key facts
- NXLLF last price: 0.61, -24.66%, as of 21 Aug 2026 20:00 GMT close
- ACV growth: Up 13% in FY 2026
- EBITDA growth: Up 60.4% in FY 2026
- Same-session benchmarks: SPY $765.72 (+0.41%), QQQ $713.44 (+0.35%), DIA $532.22 (+0.89%)
Frequently asked questions
What did Nuix report for FY 2026?
Nuix described FY 2026 as a record year. Annualised contract value rose 13%, EBITDA grew 60.4%, and the company highlighted a sharply higher contribution from its Neo platform alongside continued strategic investment in artificial intelligence and research and development. Segment-level detail beyond those headline figures was not disclosed in the material available.
What is annualised contract value and why does it matter?
Annualised contract value, or ACV, is the run-rate value of a software firm’s contracted subscriptions expressed over twelve months. It strips out the timing distortions of multi-year deals and licence recognition, making it a forward-looking proxy for next year’s revenue base. For subscription software businesses it is usually the most closely watched growth metric.
Why did EBITDA grow so much faster than ACV?
EBITDA rose 60.4% against 13% ACV growth, a gap that almost always reflects operating leverage: revenue rising against a flat or shrinking cost base. In subscription software, incremental contract value carries very high margin. The caution is that such leverage is rarely repeatable, particularly off a low prior-year earnings base.
Why did NXLLF fall 24.66% if results were a record?
NXLLF last closed at 0.61, down 24.66% from 0.81, on a day when U.S. benchmarks rose. The day’s range was 0.61 to 0.61, the signature of an extremely thin over-the-counter line where a single print can produce a large headline percentage move. The primary listing, not the OTC quote, sets the reference valuation.
What is the Neo platform?
Neo is Nuix’s newer software platform, and the company disclosed a sharply higher contribution from it in FY 2026. In platform migrations, growth rates off a small base look dramatic while legacy revenue erodes. Investors should focus on Neo’s absolute revenue and the pace of legacy decline rather than the percentage growth figure alone.
What should investors watch from here?
Key items are the split of ACV growth between new customers and expansion within existing accounts, Neo’s absolute revenue versus legacy decline, how much of the EBITDA gain converts to free cash flow after capitalised development costs, and the scale and duration of the AI and R&D programme, which determines whether FY 2026 margins are a floor or a peak.
Sources
Photo: Kampus Production · Pexels Licence — source



